OTCMKTS:MCUJF - Medicure Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Medicure Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $2.54 0.00 (0.00 %) (As of 02/19/2020 02:11 PM ET) Add Compare Today's Range$2.54Now: $2.54▼$2.5450-Day Range$2.46MA: $2.78▼$3.3452-Week Range$2.46Now: $2.54▼$5.14VolumeN/AAverage Volume313 shsMarket Capitalization$27.43 millionP/E RatioN/ADividend YieldN/ABeta0.32 ProfileAdvanced ChartEarningsHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Medicure Inc, a cardiovascular pharmaceutical company, engages in the research, clinical development, and commercialization of human therapeutics in Canada, the United States, and Barbados. The company primarily markets and sells AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction, as well as AGGRASTAT high-dose bolus regimen for the reduction of thrombotic cardiovascular events in patients with non ST elevated acute coronary syndrome. Read More… Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:MCUJF Previous Symbol CUSIPN/A CIKN/A Webhttp://www.medicure.com/ Phone204-487-7412Debt Debt-to-Equity RatioN/A Current Ratio4.20 Quick Ratio3.59Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$22.46 million Price / Sales1.22 Cash Flow$0.21 per share Price / Cash Flow12.11 Book Value$4.15 per share Price / Book0.61Profitability EPS (Most Recent Fiscal Year)N/A Net Income$3.03 million Net Margins-11.31% Return on Equity-3.55% Return on Assets-2.87%Miscellaneous EmployeesN/A Outstanding Shares10,800,000Market Cap$27.43 million Next Earnings Date5/4/2020 (Estimated) OptionableNot Optionable Receive MCUJF News and Ratings via Email Sign-up to receive the latest news and ratings for MCUJF and its competitors with MarketBeat's FREE daily newsletter. OTC:MCUJF Rates by TradingView Medicure (OTCMKTS:MCUJF) Frequently Asked Questions What is Medicure's stock symbol? Medicure trades on the OTCMKTS under the ticker symbol "MCUJF." How were Medicure's earnings last quarter? Medicure Inc. (OTCMKTS:MCUJF) announced its quarterly earnings results on Tuesday, November, 26th. The company reported ($0.03) earnings per share for the quarter. The firm earned $4.18 million during the quarter. Medicure had a negative net margin of 11.31% and a negative return on equity of 3.55%. View Medicure's Earnings History. When is Medicure's next earnings date? Medicure is scheduled to release their next quarterly earnings announcement on Monday, May 4th 2020. View Earnings Estimates for Medicure. Has Medicure been receiving favorable news coverage? Media headlines about MCUJF stock have been trending negative recently, InfoTrie reports. The research firm identifies positive and negative news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Medicure earned a media sentiment score of -2.0 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 2.0 out of 10, indicating that recent news coverage is very unlikely to have an impact on the company's share price in the near term. View News Stories for Medicure. Who are some of Medicure's key competitors? Some companies that are related to Medicure include REDHILL BIOPHAR/S (RDHL), Chimerix (CMRX), Xeris Pharmaceuticals (XERS), Savara (SVRA), Aquestive Therapeutics (AQST), Zynerba Pharmaceuticals (ZYNE), IMMUTEP LTD/S (IMMP), Northwest Biotherapeutics (NWBO), Axovant Gene Therapies (AXGT), Trillium Therapeutics (TRIL), VERONA PHARMA P/S (VRNA), Sunesis Pharmaceuticals (SNSS), TFF Pharmaceuticals (TFFP), Trevi Therapeutics (TRVI) and AVEO Pharmaceuticals (AVEO). What other stocks do shareholders of Medicure own? Based on aggregate information from My MarketBeat watchlists, some companies that other Medicure investors own include Allena Pharmaceuticals (ALNA), Viking Therapeutics (VKTX), Ampliphi Biosciences (APHB), Arbutus Biopharma (ABUS), AcelRx Pharmaceuticals (ACRX), Aldeyra Therapeutics (ALDX), Apellis Pharmaceuticals (APLS), Aquinox Pharmaceuticals (AQXP), Ardelyx (ARDX) and ArQule (ARQL). Who are Medicure's key executives? Medicure's management team includes the folowing people: Dr. Albert David Friesen, Founder, Chairman, CEO & Pres (Age 72)Mr. James F. Kinley, CFO & Sec. (Age 41) How do I buy shares of Medicure? Shares of MCUJF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab. What is Medicure's stock price today? One share of MCUJF stock can currently be purchased for approximately $2.54. How big of a company is Medicure? Medicure has a market capitalization of $27.43 million and generates $22.46 million in revenue each year. View Additional Information About Medicure. What is Medicure's official website? The official website for Medicure is http://www.medicure.com/. How can I contact Medicure? Medicure's mailing address is 2 - 1250 WAVERLEY STREET, WINNIPEG A2, R3T 6C6. The company can be reached via phone at 204-487-7412 or via email at [email protected] MarketBeat Community Rating for Medicure (OTCMKTS MCUJF)Community Ranking: 2.6 out of 5 ( )Outperform Votes: 146 (Vote Outperform)Underperform Votes: 134 (Vote Underperform)Total Votes: 280MarketBeat's community ratings are surveys of what our community members think about Medicure and other stocks. Vote "Outperform" if you believe MCUJF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MCUJF will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/19/2020 by MarketBeat.com StaffFeatured Article: Trade War
